Year: 2019
Type: review
Abstract: Telomeres, the protective structures of chromosome ends are gradually shortened by each cell division, eventually leading to senescence or apoptosis. Cancer cells maintain the telomere length for unlimited growth by telomerase reactivation or a recombination-based mechanism. Recent genome-wide analyses have unveiled genetic and epigenetic alterations of the telomere maintenance machinery in cancer. While telomerase inhibition reveals that longer telomeres are more advantageous for cell survival, cancer cells often have paradoxically shorter telomeres compared with those found in the normal tissues. In this review, we summarize the latest knowledge about telomere length alterations in cancer and revisit its rationality. Finally, we discuss the potential utility of telomere length as a prognostic biomarker.
Source: Cells
DOI: 10.3390/cells8020107
Authors: Keiji Okamoto, Hiroyuki Seimiya
Institution: Japanese Foundation For Cancer Research
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,824
Awards: Molecular basis for the cross-sectional vulnerability of various cancers elicited by atypical nucleic acid configuration and its therapeutic application, G3057698024, Synthetic lethality-based identification of drug-sensitive genome profiles, G3715251695, G6158379319, テロメアを介した遺伝子発現制御機構と腫瘍組織形態への影響の解明
OpenAlex ID: W2913259928
